Penicillin, headgillin (also known as an antibacterial ethylamide) is a common antibacterial drug for infectious diseases, as it can cause allergies and severe shock and life risk. As a result, many patients have such experience: doctors often require a skin test (skin test) prior to the prescription of such drugs, and often inject a small amount of leather fluid into the front end of the arm. If the diameter of the body of injection is expanded, or if it is red faint, it is itching, etc., then it is considered positive and this anti-bacterial drug cannot be used; otherwise, if it is not, the doctor will give the patient the comfort of using it。
However, is this method of determining whether penicillin and headgillin can be used (are they allergic to them) in itself entirely correct? Indeed, this issue has long been questioned by industry experts, and it is clearly explained in the latest national document, the guidelines for the dermal testing of antibacterials of betanetamines (2021 edition), issued by the national commission on health on 16 april 2021 (hereinafter referred to as the guiding principles)。
Penicillin antibacterial drugs, including penicillin drugs for intravenous use, penicillin drugs for oral use, and combination formulations combined with other drugs (e. G. Potassium amosicillin claviate, sodium dabatane) are subject to a penicillin test before use. It's not the same with head bacterium. The guiding principles state that the clinical prognosis value of pre-polymbacterium tests for allergies is not supported by sufficient evidence-based medical evidence, and that most manuals on anti-bacterial drugs, the guidelines for clinical application of anti-bacterial medicines and the pharmacology of the people's republic of china do not require regular pre-polycin tests. Not recommended for routine dermal tests prior to the use of a herbicide, but only in the following cases: 2 the medical instructions specify the need for a hands-on test。
The reason for the non-recommencing of the routine tests prior to the use of the sepsis is mainly that there is currently no suitable test agent for sepsis, even though the present use of a leachate in a hospital, such as diluting a sepsis to a certain concentration or using penicillin, is largely ineffective. In other words, the results obtained from the use of these primordial fluids do not predict whether the patient is really allergic to the aphrodisiac, and many positive or negative outcomes exist. In the case of false positives (the results of the test are allergies, whereas the patient is practically insensitive to the enzymes), the doctors would have abandoned the use of the enzymes, which are very good options for the safety of effectiveness for many infectious diseases. In the case of pseudo-negatives, doctors are assured that the use of headgills may delay rescue if there is serious allergy (clinically negative patients have had a skin test, medication has had a sensitive shock, and failure to rescue results in serious consequences)。
However, there are still doctors or nurses who have been decorated before using the sepsis (not in the two categories set out in the national document), and why would they be willing to do more of the decorative tests that were not required? It is also important that the content of the national document is not yet fully available and implemented, and clinically, given the current state of the patient-patient relationship, considers that, in view of the individual differences between patients and the quality of medicines, there are several procedures that reduce the risk of allergies and reduce medical disputes. (it is known from the previous analysis that a piping test for a hemorrhagic enzyme does not reduce the risk of allergies, but the result is to a certain extent misleading
So, how do we prevent and reduce the risk of hemorrhoid allergy? Clinical needs are: 1 detailed inquiry and screening of allergies; 2 close observation during the use of drugs; 3 equipped with allergies and equipment; and 4 medical personnel familiar with severe allergies。
What do patients need to do? When asked by physicians about allergies, should it be made clear that during previous treatments were there any cases of allergies? For example, did the test result be positive, or did the medication have a reaction? Is there a small rash or is there a serious allergy like shock? What is the specific drug (not all called penicillin or septococin) that has been reacted to? Was it oral or intravenous? How long after the drug's allergies? What happened? How did the doctor do the diagnosis? Wait. These will greatly assist current treating physicians in making specific analyses of patients ' allergies, leading to accurate judgements and appropriate current treatment programmes。
Of course, in order for patients to remember these details, they need to be a sensitive person in the event of such an allergy, to be recorded in a timely manner and kept in order to provide the physician with accurate allergy history information at every subsequent visit。
There are also cases in which patients need to inform their physician before the examination: for example, whether other drugs are being used. Some drugs inhibit skin reactions, leading to pseudo-negative results, such as anti-monomethamphetamines (oral or intravenous use, not external use), sugary cortex hormones, as well as antidepressants of the acetylene and antipsychotics of the cytex. If these drugs are being used, it takes 3-7 days to stop the drugs to eliminate the effects of the dermatological tests; if β-receptor retardants and vascular tension transformation enzyme inhibitors are being administered because of cardiovascular diseases? As these drugs can affect the treatment of severe allergies, patients with a high risk of severe allergies should stop the drugs for at least 24 hours before the test. Also, does the patient suffer from asthma? In the case of asthma and poor control, the test is more severe in the event of a severe allergic reaction, and therefore is best performed during the asthma control period。
In any case, the results of the test may affect the choice of the drug, and there is a risk to the test itself. Both medical personnel and patients should take a correct look at the test and understand its meaning. Medical personnel should be required to perform the test, as stipulated in the guiding principles, without having to do so, in the right way of preventing and dealing with allergies. Patients are required to be sensitive in case of allergies, to record details in a timely and detailed manner, and to accurately reflect the individual history of allergies and drug use in medical treatment. The joint efforts of the patient and the patient ultimately benefit from the treatment of the patient。
Special support from shanghaiese biopharmaceuticals inc
